Industry Reports Services Press Release
  •   Blogs
  • Contact us About us

    Europe Autoimmune Disease Diagnostics Market Forecast 2028 By Product (Systemic Autoimmune Disease {Rheumatoid arthritis, Ankylosing spondylitis, Systemic Lupus Erythematosus}, Localized Autoimmune Disease), By Test Type (Antinuclear Antibody Tests, Autoantibody Tests, C-reactive Protein (CRP), Complete Blood Count (CBC), Urinalysis), Research Report, Country Outlook (Germany, UK, France, Spain, Italy, Romania, Bulgaria, Portugal, Croatia, Greece, Lithuania, Estonia, Netherlands, Latvia, Belgium, Finland, Switzerland, Poland, Slovenia, Austria, Ireland, Czechia, Norway, Cyprus, Hungary, Sweden, Denmark), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share
    Published Date: August 2022   |   Report ID: GR1307   |   Delivery: PDF  Request Free Sample

    Europe Autoimmune Disease Diagnostics Market size crossed USD 320 million in 2021 and is poised to witness 6% CAGR from 2022 to 2028. As the incidence of rare autoimmune diseases rises, the need for effective diagnostic technologies is taking priority.

    europe autoimmune disease diagnostics market

    Get more details on this report - Request Free Sample PDF

    Over the last few years, the prevalence rate of autoimmune conditions such as type 1 diabetes mellitus, systemic lupus erythematosus, rheumatoid arthritis, Graves’ disease, and multiple sclerosis, has been steadily increasing. Since primary immune deficiencies are extremely varied in terms of symptoms and degrees of severity, patients can have problems in availing proper therapeutic and diagnostic solutions. Several companies are addressing this pain point by launching AI-powered technologies for delivering more accurate and faster results.

    It is estimated that more than 5% to 10% of the population in Europe is affected with autoimmune diseases. It has realized the considerable need for spreading awareness about the disorders and make sure people have enough access to suitable diagnosis and treatments. The severity can be understood from the fact that over 4 million people across the UK suffer from at least one autoimmune disorder. The gradual rise in patients throughout Europe will bolster the efforts to promote early diagnosis of conditions and increase the footfall across diagnostic centers.

    Impact of COVID-19 on Europe Autoimmune Disease Diagnostics Market Outlook

    The novel coronavirus pandemic has encouraged reliance on self-tests among people, for taking charge of medical needs. Companies are likely to focus on diverse segments such as diabetes patients and those with high cholesterol. Over the last couple of years, home-based blood tests for autoimmune diseases have been gaining traction due to the social restrictions imposed by governments worldwide.

    Decreased mobility of patients suffering from chronic conditions has been a key factor supporting the uptake of these products. In June 2021, Lithuania-based start-up Revolab, announced that it has developed a digital platform for tracking the overall physical wellbeing of users through a home blood test kit as well as a smartphone app, indicating future development scope across the diagnostics domain.

    Europe Autoimmune Disease Diagnostics Market, By Test Type

    The autoantibody tests segment accounted for USD 100 million revenue in 2021, due to increasing cases of systemic autoimmune conditions such as lupus and rheumatoid arthritis. As these tests are conducted using a host of devices and techniques, the installation of X-ray equipment, MRI devices, and other imaging scans, is expected to see an uptick. Several medical professionals have displayed preference for antinuclear antibody (ANA) tests for autoimmune disorders to ensure more accurate and timely diagnosis.

    Europe Market, By Product

    The localized autoimmune disease diagnostics market in Europe is anticipated to register notable gains through 2028. Today, standardized immunoassay kits are available to facilitate early detection of various diseases. Autoimmune diseases specific to certain organs can be diagnosed using suitable solutions. Government efforts for improving patient awareness regarding the diseases such as celiac disease and Crohn’s disease will strengthen the industry outlook.

    Europe Market, By Country

    France autoimmune disease diagnostics market size is expected to rise substantially during the forecast timeline. In January 2021, the French government introduced the ATRACTion program, which has received funds worth nearly USD 9.83 million. Under this program, over 11 key regional healthcare players will collaborate to develop precision medicine for patients suffering from immune deficiencies, as well as transform areas such as diagnosis and prognosis. France also has a strong healthcare sector with advanced infrastructure in place. The country had spent more than USD 209 billion on healthcare in 2020.

    Competitive Industry Landscape

    Prominent participants operating across the Europe autoimmune disease diagnostics market are Beckman Coulter, Inc., SQI diagnostics, Hemagen Diagnostics, Abbott Laboratories, Siemens Healthineers, Quest Diagnostics, Crescendo Bioscience, Inc., F. Hoffmann-La Roche Ltd, and SQI diagnostics.

    These companies have been foraying into new patient segments with innovative devices for gaining a higher industry share. For instance, in August 2022, industry leader Thermo Fisher Scientific Inc (TMO) announced that it has successfully secured FDA clearance for its new in vitro diagnostic tools for detecting sesame and wheat allergies. The advanced blood tests will serve as a major diagnostic aid for clinicians and doctors to identify severity of allergic reactions caused by foods such as milk, eggs, and peanuts. Since wheat allergy can be often linked with celiac disease, an autoimmune condition, this development represents a positive bearing for the industry.

    Frequently Asked Question(FAQ) :

    How big is the Europe autoimmune disease diagnostics industry?
    The market for autoimmune disease diagnostics in Europe had exceeded USD 320 million during 2021 and could witness over 6% CAGR between the forecast years 2022-2028.
    Why is the demand for autoantibody tests for autoimmune disease diagnosis growing in the Europe autoimmune disease diagnostics sector?
    The autoantibody tests segment was over USD 100 million in 2021 and will expand with growing prevalence of systemic autoimmune conditions such as lupus and rheumatoid arthritis.
    What are the factors expanding France autoimmune disease diagnostics market?
    France is anticipated to see a considerable rise in the demand for autoimmune disease diagnostics solution over the coming years, with an increase in consumer healthcare spending, presence of advanced medical facilities and availability of top solution providers in Europe.
    Which companies make autoimmune disease diagnostics products for Europe market?
    Beckman Coulter, Inc., SQI diagnostics, Hemagen Diagnostics, Abbott Laboratories, Siemens Healthineers, Quest Diagnostics, Crescendo Bioscience, Inc., F. Hoffmann-La Roche Ltd, and SQI diagnostics, are some of the key players in the market.

    Get this research report on Europe Autoimmune Disease Diagnostics Market customized according to your business requirements.

    report-purchase - logo Buy Now

    Why Choose us?

    • on-time delivery On-Time Delivery

      We commit to on-time delivery of reports to keep you ahead.

    • assured quality Assured Quility

      With a wide network of industry experts and trained in-house analysts, we assure best service quality.

    • Custom Research Service

      We offer research services to meet specific client requirements and provide them with actionable insights on target markets.

    • payment security Payment Security

      Our safe payment gateway gives you full control of your personal data, at all times.

    Connect with our sales team


     [email protected]